These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1316960)
1. Efficacy of continuous zidovudine infusion at early stages of retroviral infection in mice. Sinet M; Harcouet L; Desforges B; Colin JN; Farinotti R; Pocidalo JJ J Acquir Immune Defic Syndr (1988); 1992; 5(6):577-82. PubMed ID: 1316960 [TBL] [Abstract][Full Text] [Related]
2. Factors influencing zidovudine efficacy when administered at early stages of Friend virus infection in mice. Sinet M; Desforges B; Launay O; Colin JN; Pocidalo JJ Antiviral Res; 1991 Sep; 16(2):163-71. PubMed ID: 1799277 [TBL] [Abstract][Full Text] [Related]
3. Effects of zidovudine on Friend virus complex infection in Rfv-3r/s genotype-containing mice used as a model for HIV infection. Morrey JD; Warren RP; Okleberry KM; Burger RA; Johnston MI; Sidwell RW J Acquir Immune Defic Syndr (1988); 1990; 3(5):500-10. PubMed ID: 2157836 [TBL] [Abstract][Full Text] [Related]
4. Impact of dosing schedule upon suppression of a retrovirus in a murine model of AIDS encephalopathy. Bilello JA; Eiseman JL; Standiford HC; Drusano GL Antimicrob Agents Chemother; 1994 Mar; 38(3):628-31. PubMed ID: 8203866 [TBL] [Abstract][Full Text] [Related]
5. Bone marrow transplantation from Fv-4-resistant donors rescues Friend leukemia virus-infected mice from leukemia: a model of bone marrow transplantation therapy against retroviral infection. Kitagawa M; Kamisaku H; Aizawa S; Sado T Leukemia; 1994 Dec; 8(12):2200-6. PubMed ID: 7808008 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of FK-565 alone and in combination with zidovudine on retroviral infection by Friend leukemia virus in mice. Yokota Y; Wakai Y; Watanabe Y; Mine Y J Antibiot (Tokyo); 1988 Oct; 41(10):1479-87. PubMed ID: 3192497 [TBL] [Abstract][Full Text] [Related]
7. Early-initiated zidovudine therapy prevents disease but not low levels of persistent retrovirus in mice. Morrey JD; Okleberry KM; Sidwell RW J Acquir Immune Defic Syndr (1988); 1991; 4(5):506-12. PubMed ID: 2016687 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of high-dose zidovudine administered as a continuous infusion in patients with cancer. Marchbanks K; Dudley MN; Posner MR; Darnowski J Pharmacotherapy; 1995; 15(4):451-7. PubMed ID: 7479197 [TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of human lactoferrin and recombinant murine interferon-gamma on disease progression in mice infected with the polycythemia-inducing strain of the Friend virus complex. Lu L; Shen RN; Zhou SZ; Srivastava C; Harrington M; Miyazawa K; Wu B; Lin ZH; Ruscetti S; Broxmeyer HE Int J Hematol; 1991 Apr; 54(2):117-24. PubMed ID: 1660735 [TBL] [Abstract][Full Text] [Related]
10. Alteration of cytokine levels in murine retrovirus infection: modulation by combination therapy. Bowden R; Tate SM; Soto S; Specter S Int J Immunopharmacol; 1999 Dec; 21(12):815-27. PubMed ID: 10606002 [TBL] [Abstract][Full Text] [Related]
11. Development of a real-time quantitative reverse transcriptase PCR assay for detection of the Friend leukemia virus load in murine plasma. He JY; Cheng HJ; Wang YF; Zhu YT; Li GQ J Virol Methods; 2008 Feb; 147(2):345-50. PubMed ID: 18068233 [TBL] [Abstract][Full Text] [Related]
12. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice. Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370 [TBL] [Abstract][Full Text] [Related]
14. Molecular assessment of the potential combination therapy of cytokines with biphalin and AZT for Friend leukemia virus infection in vitro. Tang JL; Lipkowski AW; Specter S Pharmacol Rep; 2008; 60(2):190-8. PubMed ID: 18443380 [TBL] [Abstract][Full Text] [Related]
15. Modulation of ex vivo cytokine production by splenocytes using in vitro combined therapeutics in murine retroviral model. Kang LC; Kerben MJ; Ugen KE; Specter SC DNA Cell Biol; 1999 Jul; 18(7):585-92. PubMed ID: 10433557 [TBL] [Abstract][Full Text] [Related]
16. Intravenous and oral zidovudine pharmacokinetics and coagulation effects in asymptomatic human immunodeficiency virus-infected hemophilia patients. Morse GD; Portmore AC; Marder V; Plank C; Olson J; Taylor C; Bonnez W; Reichman RC Antimicrob Agents Chemother; 1992 Oct; 36(10):2245-52. PubMed ID: 1444306 [TBL] [Abstract][Full Text] [Related]
18. Impeded progression of Friend disease in mice by an inhibitor of retroviral proteases. Lai MH; Tang J; Wroblewski V; Dee AG; Margolin N; Vlahos C; Bowdon B; Buckheit R; Colacino J; Hui KY J Acquir Immune Defic Syndr (1988); 1993 Jan; 6(1):24-31. PubMed ID: 8093263 [TBL] [Abstract][Full Text] [Related]
19. Implications of the kinetics of zidovudine in the pregnant baboon following oral administration. Garland M; Szeto HH; Daniel SS; Tropper PJ; Myers MM; Stark RI J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):433-40. PubMed ID: 9859956 [TBL] [Abstract][Full Text] [Related]
20. The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites. Barry MG; Khoo SH; Veal GJ; Hoggard PG; Gibbons SE; Wilkins EG; Williams O; Breckenridge AM; Back DJ AIDS; 1996 Oct; 10(12):1361-7. PubMed ID: 8902065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]